J A Arranz Arija

Avelumab plus sacituzumab govitecan versus avelumab monotherapy as eerstelijns maintenance treatment in patiënten met...

Pembrolizumab plus enzalutamide versus placebo plus enzalutamide for chemotherapy-naive metastatic castration-resista...